Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Foundation Medicine has received investment from 5 venture capital firms.
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Foundation Medicine has received investment from Domain Associates, OrbiMed Advisors, Polaris Partners, Roche Venture Fund, Third Rock Ventures. These venture capital firms and investors provide both capital and strategic support.
Foundation Medicine has raised $456M in total funding, with their most recent round being a IPO. The company operates in the Biotech sector.
Foundation Medicine was founded in 2010 and is headquartered in Boston, Massachusetts.
Foundation Medicine operates in the Biotech sector. Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for...
